LENSAR, Inc.LNSRNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank35
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P35
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive growthRecovering
PeriodValue
Q3 2025-4.07%
Q2 2025-7.11%
Q1 202514.91%
Q4 202411.06%
Q3 2024-10.83%
Q2 2024-6.65%
Q1 2024-1.30%
Q4 2023-4.19%
Q3 20231.87%
Q2 2023-9.15%
Q1 20232.17%
Q4 20222.41%
Q3 2022-58.87%
Q2 2022-19.92%
Q1 202239.92%
Q4 20217.47%
Q3 20215.92%
Q2 20219.47%
Q1 20217.98%
Q4 202026.83%
Q3 202039.82%
Q2 2020-8.72%
Q1 202011.42%
Q4 2019-67.44%
Q3 2019373.85%
Q2 20190.00%
Q1 20190.00%